« Return to News | CROs/Service Providers

Iris Pharma, RxGen form strategic alliance

Tuesday, April 24, 2012 12:15 PM

Iris Pharma of France, an ophthalmic preclinical and clinical CRO, and RxGen, a Connecticut-based specialty preclinical CRO focused on the development and application of translational research models, have formed a strategic alliance to offer fully integrated “bench-to-bedside” ophthalmology research services.

Iris Pharma can offer immediate access to RxGen’s nonhuman primate ophthalmic research models and related preclinical in vivo services, via a flexible engagement model.

“The ability to offer integrated packages of services and a comprehensive and seamless program of preclinical and clinical drug development will improve our competitive position in the marketplace and generate significant value for our clients,” said Yann Quentric, head of business development and marketing at Iris Pharma.

“Effectively translating discovery to approved therapeutics demands time and cost-efficient program design and management, capitalizing on the best available preclinical test systems while maintaining a clear eye on the clinical pathway,” said Matthew Lawrence, CEO of RxGen.   

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.